Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719068 | SCV000728417 | likely benign | not provided | 2019-10-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001181637 | SCV001346820 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001181637 | SCV002626009 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-04-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002498967 | SCV002804319 | likely benign | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2021-07-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003767725 | SCV004573423 | uncertain significance | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-08-18 | criteria provided, single submitter | clinical testing | This sequence change affects codon 1279 of the FBN1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the FBN1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs59007872, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FBN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 516066). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV004002598 | SCV004814774 | likely benign | Marfan syndrome | 2024-06-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001719068 | SCV005212672 | likely benign | not provided | criteria provided, single submitter | not provided |